Assignee
IMMUNOLUX INT CORP
US·0 granted patents·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
4 records- 0156US2022228128A1Use of poxvirus with autologous induced pluripotent stem cells for vaccination and disease therapyIMMUNOLUX INT CORP·Filed 2020·Application pending·0 cites
- 0255US2023040081A1Vaccinia viral polymerase-mediated viral replicationIMMUNOLUX INT CORP·Filed 2020·Application pending·0 cites
- 0353US2025090580A1Methods and compositions for using activated lymphocytes in the treatment of diseaseIMMUNOLUX INT CORP·Filed 2022·Application pending·0 cites
- 0453US2022218818A1Smallpox vaccine and stem cells for treatment of diseaseIMMUNOLUX INT CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNOLUX INT CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →